Top compounds associated with response to CTC-260F20.3


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K90370028 CTRPv2 pan-cancer AAC -0.092 0.1
mRNA BRD-K86535717 CTRPv2 pan-cancer AAC 0.13 0.1
mRNA ruxolitinib CTRPv2 pan-cancer AAC 0.058 0.1
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.059 0.1
mRNA BRD-K03911514 CTRPv2 pan-cancer AAC -0.088 0.1
mRNA bendamustine CTRPv2 pan-cancer AAC -0.062 0.1
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.061 0.1
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.06 0.1
mRNA BRD-K64610608 CTRPv2 pan-cancer AAC -0.063 0.1
mRNA Bexarotene CTRPv2 pan-cancer AAC 0.058 0.1
Download CSV